ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Intellia Therapeutics Inc

Intellia Therapeutics Inc (0JBU)

24.34
0.00
(0.00%)
Cerrado 05 Enero 10:30AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
24.34
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
14,106
0.00 Rango del Día 0.00
24.34 Rango de 52 semanas 24.34
Capitalización de Mercado [m]
Precio Anterior
24.34
Precio de Apertura
-
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
12,349
Acciones en circulación
89,555,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.26
Beneficio por acción (BPA)
-5.37
turnover
36.28M
Beneficio neto
-481.19M

Acerca de Intellia Therapeutics Inc

Sector
In Vitro,in Vivo Diagnostics
Industria
In Vitro,in Vivo Diagnostics
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Intellia Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the London Stock Exchange with ticker 0JBU. The last closing price for Intellia Therapeutics was US$24.34. Over the last year, Intellia Therapeutics shares have traded in a share price range of US$ 24.34 to US$ 24.34.

Intellia Therapeutics currently has 89,555,000 shares in issue. The market capitalisation of Intellia Therapeutics is US$2.18 billion. Intellia Therapeutics has a price to earnings ratio (PE ratio) of -2.26.

0JBU Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10024.3424.3424.341050824.34DE
40024.3424.3424.34815424.34DE
120024.3424.3424.341234924.34DE
260024.3424.3424.34718724.34DE
520024.3424.3424.34467124.34DE
1560024.3424.3424.34183824.34DE
2600024.3424.3424.34118424.34DE

0JBU - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Intellia Therapeutics?
El precio actual de las acciones de Intellia Therapeutics es US$ 24.34
¿Cuántas acciones de Intellia Therapeutics están en circulación?
Intellia Therapeutics tiene 89,555,000 acciones en circulación
¿Cuál es la capitalización de mercado de Intellia Therapeutics?
La capitalización de mercado de Intellia Therapeutics es USD 2.18B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Intellia Therapeutics?
Intellia Therapeutics ha negociado en un rango de US$ 24.34 a US$ 24.34 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Intellia Therapeutics?
El ratio precio/beneficio de Intellia Therapeutics es -2.26
¿Cuál es el ratio de efectivo a ventas de Intellia Therapeutics?
El ratio de efectivo a ventas de Intellia Therapeutics es 29.94
¿Cuál es la moneda de reporte de Intellia Therapeutics?
Intellia Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Intellia Therapeutics?
El último ingresos anual de Intellia Therapeutics es USD 36.28M
¿Cuál es el último beneficio anual de Intellia Therapeutics?
El último beneficio anual de Intellia Therapeutics es USD -481.19M
¿Cuál es la dirección registrada de Intellia Therapeutics?
La dirección registrada de Intellia Therapeutics es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Intellia Therapeutics?
La dirección del sitio web de Intellia Therapeutics es www.intelliatx.com
¿En qué sector industrial opera Intellia Therapeutics?
Intellia Therapeutics opera en el sector IN VITRO,IN VIVO DIAGNOSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M
TenKay TenKay 3 minutos hace
It’s nice to see that people still don’t understand what was actually happening. LOL.

They see the word “short” and make up the rest.
HMBL
jbog jbog 4 minutos hace
Enata

Some nice info has recently been posted about Enanta's situation.

Let's all admit the truth that Enta made some real bad decisions and then caught a real bad break.

-In 2017 when Mavyret was approved Enta was sitting pretty, $315 mil in cash and e
skitahoe skitahoe 4 minutos hace
I don't know how I missed this post here, but it's the last one posted over on IV and I really think it warrants another look, and perhaps being stickied by the moderators.

https://www.investorvillage.com/smbd.asp?mb=6543&mn=17449&pt=msg&mid=25317231

Perhaps I was so in
NWBO
TheRealMrPirate TheRealMrPirate 5 minutos hace
” style="color: rgba(29, 38, 46, 1); font-size: 18px"Now why would we bid on the Sub of the company that we owned shares in"
color="#1d262e" style="font-size: 18px"No one here has any clue what you're talking about including you.
color="#1d262e" style="font-size:
doc2016 doc2016 6 minutos hace
Call ansys.
prototype_101 prototype_101 6 minutos hace
20 MILLION Shorts Covering Deadline Established June 2025, the gauntlet was put down with the issuance of the new CEO and President Incentive Options being FULLY VESTED in 6 months or June of 2025, this is an UNPRECEDENTED MOVE in the entire history of LWLG!! Normally these types of Incentive Compen
LWLG
oldstocks oldstocks 6 minutos hace
Jusde i have been a member since the 1st year they started. Back then most of us were using a different message board or two…
Ragging Bull shut down
SiliconInvestor faded
Yahoo finance message boards stopped
Twitter X you can’t post much in a post
Stocktwits is a
AFFU
DonVance DonVance 6 minutos hace
Why would that double the price?
BTCUSD
prototype_101 prototype_101 7 minutos hace
Lebby Podcast--->"Failure Mechanisms" = Qualification of 4x200 PIC

Lebby's Podcast----> SMOKING GUN PROOF OF LATE-STAGE QUALIFICATIONS

Investors also learned from the Podcast just before Lebby's abrupt departure that LWLG was proving out to be MORE ROBUST than even Leb
LWLG
Shawonsarker84 Shawonsarker84 7 minutos hace
Don't forget WSCG connection with real estate.

WSCG, Inc. is guided by a team of experienced real estate professionals with over $1.5 billion in real estate development and management expertise in the Mountain West region.

 

WSCG will focus on the conver
HMBL
Ikeboogie Ikeboogie 8 minutos hace
The bank must hold the payment for 60 days
PHIL
ChannelTrader ChannelTrader 8 minutos hace
Yep ... Canadian PM Justin Trudeau to announce resignation as early as Monday: report

https://www.foxnews.com/world/canadian-pm-justin-trudeau-announce-resignation-early-monday-report

Prime Minister Justin Trudeau is reportedly expected to resign from his position as ea
WeTheMarket WeTheMarket 9 minutos hace
Posted 3 days ago.

https://www.youtu.be/7NdcbYzNVyM?si=6d0W8g88o2V1bBX9
NKLA
real777mellon real777mellon 10 minutos hace
https://x.com/RadarHits/status/1830202479490834769

Political is not a word I use. Targeted. From here out - Targeted is allowed.

So is detailed court fallout in this NEW incoming administration. It's called POLICY changes.

No more personal attacks. As fo
LEHNQ
georgejjl georgejjl 10 minutos hace
Now many catalysts are in progress???

Alzheimer’s disease: Data from the blarcamesine Phase 2b/3 ANAVEX®2-73-AD-004 trial to be published in an upcoming peer-reviewed journal to be published SOON in the JPAD peer reviewed journal

Alzheimer’s disease: Full regulatory
AVXL
jimr1717 jimr1717 10 minutos hace
ATMH DD>> 🏆️


Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobile Analy
ATMH
OMOLIVES OMOLIVES 10 minutos hace
I can't believe we were born in the same hospital. I don't think anyone here can even comprehend how rare this is given where it was...lol. The current population there is less than 3400 lol...lol.

In 1940...it was less than 6500. That is mind boggling and crazy cool.
BDEZ BDEZ 10 minutos hace
No mas Trudeau, he quit.
Retire43 Retire43 11 minutos hace
For all of you, Pharma tech people out there read this:

BIXT
joe botts joe botts 11 minutos hace
Not much downside left , we are 1 tick from no bid.
TONR
Vexari Vexari 12 minutos hace
Interesting

To say the least

Dive bomber

In and out
PFE
Ecomike Ecomike 13 minutos hace
Just watch my Sunday morning news programs. Seems bird flu is huge problem and Biden administration is stockpiling vaccines. Did I understand correctly Bioxy has something drug for this?

Yes you did. It is 100% non toxic, oral pill, safe for Humans, not a vaccine, but a 100% c
BIXT
Eli's Gone Eli's Gone 13 minutos hace
Wasn't much fun today for the Bengals watching the Chiefs lay down and get bageled by Denver with Cincy's playoff fate on the line----I know, I know it was Cincy's fault that they were in that position---but still
flipper44 flipper44 13 minutos hace
.















NWBO
flipper44 flipper44 13 minutos hace
Really hoping LP rips shorts and other manipulators a new one. Have a good evening.
NWBO

Su Consulta Reciente